Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
<p>Abstract</p> <p>Background</p> <p>Oxaliplatin is a key drug in the treatment of colorectal cancer, but it causes severe peripheral neuropathy. We previously reported that oxaliplatin (4 mg/kg, i.p., twice a week) induces mechanical allodynia in the late phase in rats...
Main Authors: | Shirahama Masafumi, Ushio Soichiro, Egashira Nobuaki, Yamamoto Shota, Sada Hikaru, Masuguchi Ken, Kawashiri Takehiro, Oishi Ryozo |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-04-01
|
Series: | Molecular Pain |
Online Access: | http://www.molecularpain.com/content/8/1/26 |
Similar Items
-
Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats
by: Shota Yamamoto, et al.
Published: (2015-09-01) -
RgIA4 Prevention of Acute Oxaliplatin-Induced Cold Allodynia Requires α9-Containing Nicotinic Acetylcholine Receptors and CD3<sup>+</sup> T-Cells
by: Peter N. Huynh, et al.
Published: (2022-11-01) -
L-Type Ca<sup>2+</sup> Channel Regulation by Calmodulin and CaBP1
by: James B. Ames
Published: (2021-12-01) -
Regulation of ErbB Receptors by the Ca<sup>2+</sup> Sensor Protein Calmodulin in Cancer
by: Antonio Villalobo
Published: (2023-02-01) -
Ca<sup>2+</sup>–Calmodulin Dependent Wound Repair in <i>Dictyostelium</i> Cell Membrane
by: Md. Shahabe Uddin Talukder, et al.
Published: (2020-04-01)